Plain-English translation of NCT06572046 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term registry study for people with hereditary spastic paraplegia (HSP), a group of rare genetic conditions affecting the nervous system. Rather than testing a new medication, this study is building a detailed registry of patients with HSP by collecting information from regular clinical visits over time. The goal is to better understand how HSP progresses in different people and to help develop future treatments.
Hereditary spastic paraplegia is rare and affects different people in different ways, making it hard for doctors to understand the disease and develop treatments. By gathering consistent information from many patients over several years, researchers hope to identify patterns that will help them create better therapies in the future.
You likely qualify if…
You likely don't qualify if…
You would visit one of five participating hospitals or research centers at least once per year for check-ups. At each visit, doctors would perform a standard neurological exam, ask about your medical history, give you questionnaires about how the condition affects your daily life, and may collect blood, urine, or tissue samples. The study may also gather results from brain imaging (MRI) or eye tests you've already had done for clinical care. All your information would be entered into a secure database to help researchers study how your condition changes over time.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Italy
Sponsor
IRCCS Fondazione Stella Maris
Collaborators
IRCCS Eugenio Medea, Università degli studi di Messina
Enrollment target
~500 participants
Started
January 2024
Primary completion
December 2027
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Filippo M Santorelli, Dr.
IRCCS Fondazione Stella Maris
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.